Cargando…
Hepatic Ischemia and Reperfusion Injury in the Absence of Myeloid Cell-Derived COX-2 in Mice
Cyclooxygenase-2 (COX-2) is a mediator of hepatic ischemia and reperfusion injury (IRI). While both global COX-2 deletion and pharmacologic COX-2 inhibition ameliorate liver IRI, the clinical use of COX-2 inhibitors has been linked to increased risks of heart attack and stroke. Therefore, a better u...
Autores principales: | Duarte, Sergio, Kato, Hiroyuki, Kuriyama, Naohisa, Suko, Kathryn, Ishikawa, Tomo-o, Busuttil, Ronald W., Herschman, Harvey R., Coito, Ana J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018446/ https://www.ncbi.nlm.nih.gov/pubmed/24819536 http://dx.doi.org/10.1371/journal.pone.0096913 |
Ejemplares similares
-
Matrix Metalloproteinase-2 (MMP-2) Gene Deletion Enhances MMP-9 Activity, Impairs PARP-1 Degradation, and Exacerbates Hepatic Ischemia and Reperfusion Injury in Mice
por: Kato, Hiroyuki, et al.
Publicado: (2015) -
Conditional Bicistronic Cre Reporter Line Expressing Both Firefly Luciferase and β-galactosidase
por: Ishikawa, Tomo-o, et al.
Publicado: (2010) -
Comparative Study on the Cytoprotective Effects of Activated Protein C Treatment in Nonsteatotic and Steatotic Livers under Ischemia-Reperfusion Injury
por: Matsuda, Akitoshi, et al.
Publicado: (2015) -
Reversible Suppression of Cyclooxygenase 2 (COX-2) Expression In Vivo by Inducible RNA Interference
por: Zaiss, Anne K., et al.
Publicado: (2014) -
The Impact of Dabigatran Treatment on Sinusoidal Protection Against Hepatic Ischemia/Reperfusion Injury in Mice
por: Noguchi, Daisuke, et al.
Publicado: (2020)